A Squalene-Based Nanoemulsion for Therapeutic Delivery of Resiquimod
Agonists for toll-like receptors (TLRs) have shown promising activities against cancer. In the present study, a squalene-based nanoemulsion (NE) was loaded with resiquimod, a TLR7/8 agonist for therapeutic delivery. R848 NE was developed and characterized for long-term stability. In vitro and in viv...
Saved in:
Main Authors: | Zhongkun Zhang (Author), Jimmy Chun-Tien Kuo (Author), Chi Zhang (Author), Yirui Huang (Author), Zerui Zhou (Author), Robert J. Lee (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimized Liposomal Delivery of Bortezomib for Advancing Treatment of Multiple Myeloma
by: Chi Zhang, et al.
Published: (2023) -
Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer
by: Griffin Pauli, et al.
Published: (2021) -
CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials
by: Zhongkun Zhang, et al.
Published: (2021) -
Topically Applied Resiquimod versus Imiquimod as a Potential Adjuvant in Melanoma Treatment
by: Supreeda Tambunlertchai, et al.
Published: (2022) -
Squalene Biosynthesis in Engineered <i>Escherichia Coli</i>
by: Wei Zhang, et al.
Published: (2023)